With expertise in surface chemistry and plasma physics, PVA TePla America develops atmospheric and low-pressure plasma equipment and processes, which are proven to be cost-efficient and environmentally friendly for enhancing surfaces.
The continued evolution of the medical device industry is being propelled by our ever-aging population. According to the US census, by 2050, at least one in five Americans will be over the age of 65, and, globally, it is estimated the proportion of the population over 60 years of age will double and reach an estimated two billion.
We have a need and a ceaseless desire for new advances in patient care that increase patient longevity, and improve patient comfort and ease of use for doctors. In addition, designers of these medical devices now have to take into account the disposability of a device and its potential for reuse if possible, in an effort to help ease medical care costs.
Many new types of devices classified as 'combinatorial products' are being developed that integrate pharmaceutical agents, biofabricated materials, electronic features and a new wave of recently FDA-approved microelectromechanical systems (MEMS).
Combinatorial products pose significant challenges for designers because of interfacial compatibility, such as cleanliness, bondability and chemical functionality, and in some cases the devices have subcomponents that share opposing requirements, such as surface hydrophilic and hydrophobic properties.
New FDA regulations implemented in 2012 were meant to ensure the proper assessment of stability and longevity of existing and new devices. PVA TePla has been working to develop new solutions to help the leading manufacturers tackle the challenges associated with improving device functionality and reliability.
Located in Corona, California, US, PVA TePla America is a subsidiary of PVA TePla AG, a German public company. It is an ISO 9001-certified company that has been in business for 45 years, developing atmospheric and low-pressure plasma equipment and processes, which have proven to be cost-efficient and environmentally friendly for enhancing surfaces.
PVA TePla's California office has a large, fully equipped development laboratory, contract service centre and manufacturing centre. The group's key expertise is in surface chemistry and plasma physics. The talented R&D and sales team consists of an interdisciplinary team of PhD scientists and chemical engineers all focused on the surface treatment of materials.
When it comes to surface treatments and, in particular, combinatorial products, PVA TePla stands alone in its capabilities. PVA TePla has provided medical device manufacturers and many of the world's contract surface treatment and coating suppliers with the equipment and process knowledge necessary to take a product through all the phases of R&D, qualification, intellectual property development, contract services, FDA approval and beyond into high-volume manufacturing.
The latest IoN plasma equipment was designed specifically for the medical devices industry. The system software has very advanced capabilities and can be configured to meet the FDA CFR Title 21 Part 11 software compliance rules.
The systems are reported by PVA TePla's customers to be the best-in-class plasma-treatment systems available today. PVA TePla's plasma-enhanced chemical vapour deposition (PECVD) has become the industry standard for the deposition of complex chemistries and multistep processing for atomic layering or superhydrophobic coatings.
If you are seeking a solution to a material problem that may be solved by enhancing surface performance via cleaning or activating, grafting a polymer coating or creating surface architecture, PVA TePla is a great place to start getting real answers to those difficult material or chemistry questions.